Federal Register
Notices
> Manufacturers 2008 >
Noramco Inc.,
FR Doc E8-6384[Federal Register: March 28, 2008 (Volume 73, Number 61)]
[Notices] [Page 16712] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28mr08-111]
[[Page 16712]]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 31, 2007 and published in the Federal Register on
November 7, 2007, (72 FR 62873), Noramco Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
Drug
|
Schedule
|
Codeine-N-Oxide (9053)
|
I
|
Morphine-N-Oxide (9307)
|
I
|
Amphetamine (1100)
|
II
|
Methylphenidate (1724)
|
II
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Hydrocodone (9193)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Oxymorphone (9652)
|
II
|
Alfentanil (9737)
|
II
|
Sufentanil (9740)
|
II
|
Carfentanil (9743)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the schedule I
controlled substances for internal testing; the schedule II controlled
substances will be manufactured in bulk for distribution to its customers.
By correspondence dated March 5, 2008, Noramco has withdrawn their request
for Opium, raw (9600) and Poppy Straw (9650). No comments or objections have
been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined
that the registration of Noramco Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this time. DEA
has investigated Noramco Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with State and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance
with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: March 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6384 Filed 3-27-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|